{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:07:38Z","timestamp":1759032458592},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["psy-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.psychres.2013.07.012","type":"journal-article","created":{"date-parts":[[2013,9,3]],"date-time":"2013-09-03T18:46:35Z","timestamp":1378233995000},"page":"745-750","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cost analysis of risperidone long-acting injection in the treatment of schizophrenia and schizoaffective disorders in Hong Kong: An approach using generalised estimating equations"],"prefix":"10.1016","volume":"210","author":[{"given":"David Bin-Chia","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin Ho Ming","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai Sau","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle Pui Yu","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian Wing Yan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming Cheuk","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth Kwing Chin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.psychres.2013.07.012_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/schbul\/17.3.475","article-title":"Assessment issues and the cost of schizophrenia","volume":"17","author":"Andreasen","year":"1991","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.psychres.2013.07.012_bib2","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z","article-title":"Extending the simple linear regression model to account for correlated responses: an introduction to generalized estimating equations and multi-level mixed modelling","volume":"17","author":"Burton","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"11","key":"10.1016\/j.psychres.2013.07.012_bib3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2165\/11537680-000000000-00000","article-title":"Comparative effectiveness of long-acting risperidone in New Zealand: a report of resource utilization and costs in a 12-month mirror-image analysis","volume":"30","author":"Carswell","year":"2010","journal-title":"Clinical Drug Investigation"},{"issue":"2","key":"10.1016\/j.psychres.2013.07.012_bib4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1176\/ps.49.2.196","article-title":"Compliance with medication regimens for mental and physical disorders","volume":"49","author":"Cramer","year":"1998","journal-title":"Psychiatric Services"},{"issue":"1","key":"10.1016\/j.psychres.2013.07.012_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4088\/JCP.08l04447","article-title":"Long-acting injectable risperidone and hospital readmission: a mirror-image study using a national claim-based database in Taiwan","volume":"70","author":"Chang","year":"2009","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2013.07.012_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.euroneuro.2004.07.003","article-title":"Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets","volume":"15","author":"Chue","year":"2005","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2013.07.012_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJMoa002028","article-title":"A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia","volume":"346","author":"Csernansky","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.psychres.2013.07.012_bib8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1600-0447.1971.tb03699.x","article-title":"The contribution of fluphenazine enanthate and decanoate in the prevention of readmission of schizophrenic patients","volume":"47","author":"Denham","year":"1971","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.psychres.2013.07.012_bib9","series-title":"Analysis of longitudinal data","author":"Diggle","year":"1994"},{"key":"10.1016\/j.psychres.2013.07.012_bib10","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4088\/JCP.v64n1017","article-title":"Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic","volume":"64","author":"Fleischhacker","year":"2003","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2013.07.012_bib11","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1176\/appi.ajp.158.11.1835","article-title":"Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia","volume":"158","author":"Gitlin","year":"2001","journal-title":"American Journal of Psychiatry"},{"issue":"suppl. 10","key":"10.1016\/j.psychres.2013.07.012_bib12","first-page":"50","article-title":"Pharmacoeconomic evaluation of antipsychotic therapy for schizophrenia","volume":"58","author":"Glazer","year":"1997","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.psychres.2013.07.012_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/00019053-200523001-00002","article-title":"Pharmacoeconomics of long-acting risperidone: results and validity of cost-effectiveness models","volume":"23","author":"Haycox","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.psychres.2013.07.012_bib14","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1046\/j.1467-0658.2001.00137.x-i1","article-title":"Schizophrenia costs and treatment cost-effectiveness","volume":"102","author":"Knapp","year":"2000","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"1","key":"10.1016\/j.psychres.2013.07.012_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-244X-12-25","article-title":"Long acting risperidone in Australian patients with chronic schizophrenia: 24-month data from the e-STAR database","volume":"12","author":"Lambert","year":"2012","journal-title":"BMC Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2013.07.012_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.psychres.2008.06.043","article-title":"Effectiveness of a psychosocial intervention for relapse prevention in patients with schizophrenia receiving risperidone via long-acting injection","volume":"175","author":"Lee","year":"2010","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2013.07.012_bib17","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1176\/appi.ajp.160.7.1209","article-title":"Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials","volume":"160","author":"Leucht","year":"2003","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2013.07.012_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"issue":"12","key":"10.1016\/j.psychres.2013.07.012_bib19","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.psychres.2013.07.012_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/00048677609159495","article-title":"A mirror image out-patient study at a depot phenothiazine clinic","volume":"10","author":"Marriott","year":"1976","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2013.07.012_bib21","unstructured":"National Institute for Clinical Excellence., 2011. Guidance on the use of newer (atypical) antipsychotic drugs for the prevention of relapse in patients with schizophrenia [online].Retrieved from: \u3008http:\/\/guidance.nice.org.uk\/TA43\u3009."},{"key":"10.1016\/j.psychres.2013.07.012_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-0447.2006.00980.x","article-title":"Thirty-five months experience of risperidone long-acting injection in a UK psychiatric service including a mirror-image analysis of in-patient care","volume":"116","author":"Niaz","year":"2007","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.psychres.2013.07.012_bib23","first-page":"316","article-title":"Fluphenazine decanoate maintenance in schizophrenia: a retrospective study","volume":"83","author":"Polonowita","year":"1976","journal-title":"The New Zealand Medical Journal"},{"issue":"Suppl 16","key":"10.1016\/j.psychres.2013.07.012_bib24","first-page":"14","article-title":"Relapse and rehospitalization: Comparing oral and depot antipsychotics","volume":"64","author":"Schooler","year":"2003","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2013.07.012_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1600-0447.2009.01352.x","article-title":"Risperidone long-acting injection: a 6-year mirror-image study of healthcare resource use","volume":"120","author":"Taylor","year":"2009","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"s3","key":"10.1016\/j.psychres.2013.07.012_bib26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1524-4733.2009.00630.x","article-title":"Cost-Effectiveness of Long-Acting Risperidone Injection versus Alternative Atypical Antipsychotic Agents in Patients with Schizophrenia in China","volume":"12","author":"Yang","year":"2009","journal-title":"Value in health"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178113003879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178113003879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T08:27:53Z","timestamp":1539419273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178113003879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0165178113003879"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2013.07.012","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost analysis of risperidone long-acting injection in the treatment of schizophrenia and schizoaffective disorders in Hong Kong: An approach using generalised estimating equations","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2013.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}